{'fraction_non_alphanumeric': 0.029792746113989636, 'fraction_numerical': 0.0, 'mean_word_length': 6.653465346534653, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
CO‐ULTRAMICRONIZED PEALUT: A NEW THERAPEUTIC TREATMENT IN AUTISM SPECTRUM DISORDER

Autism spectrum disorders (ASDs) are neurodevelopmental disorders characterized by neurological deficits, especially as related to cognitive function. Brain inflammation can be a key element in the pathogenesis of neuropsychiatric disorders, such as ASD. N‐palmitoylethanolamide (PEA) is a parent molecule of ALIAmides, known for its anti‐inflammatory, analgesic and neuroprotective properties. Flavonoids, such as luteolin, possess neuroprotective actions in central nervous pathophysiological conditions. Association of PEA with Luteolin (co‐ultra PEALut) displays neuroprotective and anti‐inflammatory actions in CNS pathologies which are superior when compared to each molecule alone.